The European Committee for Medicinal Products for Human Use has recommended refusal of marketing authorizations for Cinainu, an herbal medicine for alopecia in children, and Kizfizo, a treatment for neuroblastoma in children. Cinainu contains herbal extracts of onion, lemon, guarana, and cocoa but did not prove effective in treating alopecia in a study. Kizfizo, a temozolomide-based treatment for high-risk neuroblastoma, had limited evidence of efficacy. The committee raised concerns about the study data presented by the companies and the safety and quality of the medicines. Both applications were refused marketing authorization due to the lack of demonstrated benefits outweighing the risks.
Source link
Europe Rejects Cinainu (Alopecia) & Kizfizo (Neuroblastoma)
